Description
CJC-1295 without DAC | GHRH (1-29) Analog – Research Peptide
CJC-1295 without DAC, referred to in the literature as modified GRF (1-29), is a synthetic 29-amino-acid analog of the biologically active fragment of growth hormone-releasing hormone. It carries stabilising amino acid substitutions but omits the Drug Affinity Complex.
Without albumin conjugation it exhibits a markedly shorter circulating half-life than the DAC-bearing form, and the two are frequently compared side by side in pharmacokinetic research.
Common research applications: GHRH receptor binding studies, comparative pharmacokinetic research, and growth hormone secretagogue model systems.
Specifications
| Compound | CJC-1295 without DAC |
|---|---|
| Quantity | 5mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is CJC-1295 without DAC?
CJC-1295 without DAC is a stabilised GHRH (1-29) analog, also known as modified GRF (1-29), without the albumin-binding Drug Affinity Complex.
What is CJC-1295 without DAC studied for?
It is used in GHRH receptor research and in half-life comparisons against the DAC-bearing form. All work is laboratory research only.
What purity is CJC-1295 without DAC 5mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
📚 Research guide: Read our Sermorelin vs Ipamorelin vs CJC-1295: GHRH and Ghrelin Receptor Routes Compared
Research guide: Ipamorelin and CJC-1295 research overview
Reviews
There are no reviews yet.